Literature DB >> 31086602

Protective effects of Asiatic acid against pelvic inflammatory disease in rats.

Dejia Kong1, Ping Fu2, Qin Zhang2, Xian Ma2, Ping Jiang2.   

Abstract

Asiatic acid (AA) is one of the major components of the Chinese herb Centella asiatica and exerts a variety of pharmacological activities. However, the pharmacological effects of AA on pelvic inflammatory disease (PID) remain unknown. The purpose of the present study was to investigate the therapeutic efficacy and potential mechanisms of AA on PID in rats. A total of 75 female Sprague Dawley rats were randomly divided into the following five groups: A control group; a PID group; a PID + AA 5 mg/kg group; a PID + AA 35 mg/kg group; and a PID + AA 75 mg/kg group. Changes in cytokine and chemokine levels, myeloperoxidase (MPO) activity, nucleotide-binding domain-like receptor protein 3 (NLRP3) inflammasome and nuclear factor-κB (NF-κB) activation, oxidative stress and cleaved caspase-3 were measured. AA treatment significantly decreased the excessive production of cytokines and chemokines and suppressed MPO activity and the activation of NLRP3 inflammasome, NF-κB and caspase-3, as well as oxidative stress. These results suggest that AA exhibits potent anti-inflammatory and antioxidant effects in rats with pathogen-induced PID and that the mechanism of these anti-inflammatory effects may be associated with the suppression of NLRP3 inflammasome activation and the NF-κB pathway.

Entities:  

Keywords:  asiatic acid; inflammatory response; nuclear factor-κB; nucleotide-binding domain-like receptor protein 3 inflammasome; pelvic inflammatory disease

Year:  2019        PMID: 31086602      PMCID: PMC6488995          DOI: 10.3892/etm.2019.7498

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  6 in total

Review 1.  Recent Advances Regarding the Molecular Mechanisms of Triterpenic Acids: A Review (Part I).

Authors:  Marius Mioc; Andreea Milan; Daniel Malița; Alexandra Mioc; Alexandra Prodea; Roxana Racoviceanu; Roxana Ghiulai; Andreea Cristea; Florina Căruntu; Codruța Șoica
Journal:  Int J Mol Sci       Date:  2022-07-13       Impact factor: 6.208

2.  NLRP3 inflammasome inhibitor MCC950 attenuates primary dysmenorrhea in mice via the NF-κB/COX-2/PG pathway.

Authors:  Biao Tang; Dan Liu; Lingyu Chen; Yu Liu
Journal:  J Inflamm (Lond)       Date:  2020-06-24       Impact factor: 4.981

3.  Endothelial damage and a thin intercellular fibrin network promote haemorrhage in acute promyelocytic leukaemia.

Authors:  Chunxu Wang; Muxin Yu; Peng Zhou; Baorong Li; Yingmiao Liu; Lixiu Wang; Xiaojing Chen; Jingwen Du; Yufeng Wang; Jinming Zhang; Haijiao Jing; Yiming Feng; Yue Zhang; Yueyue Li; Zengxiang Dong; Shaohong Fang; Valerie A Novakovic; Jin Zhou; Jialan Shi
Journal:  EBioMedicine       Date:  2020-09-16       Impact factor: 8.143

Review 4.  Evidence for the Use of Complementary and Alternative Medicine for Pelvic Inflammatory Disease: A Literature Review.

Authors:  Dongmei Wang; Yue Jiang; Jiaxing Feng; Jingshu Gao; Jinlan Yu; Jing Zhao; Pihong Liu; Yaguang Han
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-19       Impact factor: 2.629

5.  Bioinformatic Characterization of Whole Blood Neutrophils in Pelvic Inflammatory Disease: A Potential Prognostic Indicator for Transumbilical Single-Port Laparoscopic Pelvic Abscess Surgery.

Authors:  Haining Li; Yanling Hu; Dan Liu; Juanjuan Wang; Panpan Han; Nan Zhang; Yan Li
Journal:  Comput Math Methods Med       Date:  2022-04-01       Impact factor: 2.238

6.  The Potential of Asiatic Acid in the Reversion of Cyclophosphamide-Induced Hemorrhagic Cystitis in Rats.

Authors:  Andrzej Wróbel; Łukasz Zapała; Tomasz Kluz; Artur Rogowski; Marcin Misiek; Kajetan Juszczak; Jacek Sieńko; Daniela Gold; Klaudia Stangel-Wójcikiewicz; Ewa Poleszak; Piotr Radziszewski
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.